Want to join the conversation?
$ACET's 4Q16 net sales fell 7.6% to $135.4MM versus 4Q15. Human Health segment sales fell 18.2% due to greater price competition at Rising Pharmaceuticals. Pharmaceutical Ingredients grew 11.3%, driven by rise in sales of Active Pharmaceutical Ingredients sold abroad. Performance Chemicals sales fell 8.6% due to lower sales of specialty chemicals.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!